In both our DASL data (S8b Fig) and TCGA RNAseq data (S8d Fig), there was significantly higher expression of ARG2 in tumor samples in the young than the older cohort, which may suggest a stronger oncogenic role of ARG2 in the development of prostate cancer in young men. The gene discussed is ARG2; the disease is prostate cancer.